Sun Pharma, Jindal Steel among top stocks to buy, sell; intraday chart suggests Nifty may fall up to 14,130
时间:2024-06-29 02:40:36 阅读(143)
By Shrikant Chouhan
The market registered an extremely volatile session, the Nifty/ Sensex closed 63/243 points lower. The Nifty/ Sensex failed to sustain above the 14500/48400 resistance mark and due to consistent selling pressure at higher levels along with tepid global cues the benchmark index corrected sharply. Among sectors, profit booking was seen in IT stocks whereas, Auto, Pharma and selective Media stocks witnessed buying interest.
Jindal Steel and Power Ltd BUY, CMP: Rs 431.55, TARGET: Rs 455, SL: Rs 420
On the daily time frame, after the sharp up move, the stock was into a consolidation phase and finally, it has given a breakout from its Flag chart pattern with incremental volume activity indicating further up move in the coming horizon.
Sun Pharmaceutical Industries LtdBUY, CMP: Rs 645.15, TARGET: Rs 675, SL: Rs 630
The stock is trading into a rising channel pattern making the higher top and higher bottom series on weekly and monthly charts, therefore all major technical trend indicators such as MACD and ADX are strong and intact. Thus upward movement from the current level is very likely to remain in the near term.
Bata IndiaSELL, CMP: Rs 1,297.65, TARGET: Rs 1,230, SL: Rs 1,330
The stock is in a downtrend where the bears are quite strong at the moment as bulls are not able to gain strength, on the monthly scale as well the stock is trading below its rising trend line and short-term moving averages which indicates bearishness in the counter.
RBL Bank SELL, CMP: Rs 174.55, TARGET: Rs 165, SL: Rs 180
Bearish continuation formation is evident in the counter as it is continuously making lower high and lower lows, hence the overall structure of the stock suggest that it is heading to its previous demand zone on the downside
(Shrikant Chouhan is Executive Vice President (Equity Technical Research), Kotak Securities. Views expressed are the author’s own.)
猜你喜欢
- Rupee depreciation, inflation, RBI rate hike triple whammy for biz, consumers; INR may hit 78
- Rupee falls 18 paise to close at 81
- Blogger’s Park- Catching them young
- Rupee likely to appreciate amid rising risk appetite in global markets; USDINR pair to trade in this range
- Elon Musk’s astounding surge in wealth- From $24 billion to $219 billion in just two years
- Bond yield rises further ahead of weekly auction
- Best and worst performing Nifty 50 stocks of 2022- Index up 4% year-to-date, these sectors driving gains
- Biocon Biologics partners with Sandoz for distribution of its biosimilar to treat immune-related diseases in Japan
- Bond yields surge, time to lock high returns; here’s how to choose debt securities, duration, allocation